Interferon alpha-2a biosimilar (Rhein Minapharm Biogenetics) | Interleukin Related interleukin-related.com

Product Name :
Interferon alpha-2a biosimilar (Rhein Minapharm Biogenetics)

Search keywords :
Rhein

drugId :
null

Target Vo:
Interferon alpha/beta receptor

Target Vo Short Name :
IFNAR

Moa_Name:
Immunomodulators

First Approval Country :
Egypt

First Approval Date Filter:
2005

Origin Company_Name :
Rhein Minapharm Biogenetics

Active Company_Name :
Rhein Minapharm Biogenetics

Active Indication_Name:
Hepatitis C

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PDGFR alpha Antibody
AHR Antibody
VDAC1 Antibody: VDAC1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to VDAC1. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts